ADC Therapeutics Cuts Workforce To Advance ZYNLONTA Portfolio In B-Cell Lymphoma

ADC Therapeutics SA (ADCT), a commercial-stage biotechnology company, announced it has initiated a strategic reorganisation, including a workforce reduction, to focus resources on key initiatives to advance the ZYNLONTA franchise.